0001104659-21-002487.txt : 20210108
0001104659-21-002487.hdr.sgml : 20210108
20210108163042
ACCESSION NUMBER: 0001104659-21-002487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210106
FILED AS OF DATE: 20210108
DATE AS OF CHANGE: 20210108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY WILLIAM GARRETT
CENTRAL INDEX KEY: 0001692961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 21517795
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET,
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212-554-4366
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tm212167-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-01-06
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0001692961
GRAY WILLIAM GARRETT
2 GANSEVOORT ST
9TH FLOOR
NEW YORK
NY
10014
0
1
0
0
Chief Financial Officer
COMMON STOCK (RESTRICTED)
2021-01-06
4
A
0
151000
0.00
A
508490
D
The shares of restricted stock vest as follows: one-fourth on January 6, 2022, one-fourth on January 6, 2023, one-fourth on January 6, 2024 and one-fourth on January 6, 2025.
Includes shares of restricted Common Stock, which vest over various time periods.
/s/ Garrett Gray
2021-01-08